Estrogen: Béda antara owahan

Konten dihapus Konten ditambahkan
Arupako (parembugan | pasumbang)
c →‎top: éjaan, replaced: yaiku → ya iku (3) using AWB
c →‎top: éjaan using AWB
Larik 16:
| title = UGT1A1 Genetic Polymorphisms, Endogenous Estrogen Exposure, Soy Food Intake, and Endometrial Cancer Risk
| work = Vanderbilt Epidemiology Center, Department of Medicine and Vanderbilt-Ingram Cancer Center, Nashville, Tennessee and Department of Epidemiology, Shanghai Cancer Institute, Cancer Institute of Shanghai Jiao Tong University; Sandra L. Deming, Wei Zheng, Wang-Hong Xu, Qiuyin Cai, Zhixian Ruan, Yong-Bing Xiang dan Xiao-Ou Shu
}}(Kaunduh 30/1/13)</ref> Mekanisme klasik estrogen bakal duweni pengaruh tumprap laju dalan [[mitosis]] lan [[apoptosis]] lan ngejawantah dadi risiko kanker payudara kanti ngaruhi pertumbuhan [[sel epitelial|jaringan epitelial]]. Laju [[proliferasi]] [[sel (biologi)|sel]] kang cepet banget bakal gawé sel dadi rentan tumprap kesalahan [[gen]]etika nalika proses [[replikasi DNA]] deningdéning senyawa [[spesi oksigen reaktif]] kang teraktivasi deningdéning [[metabolit]] estrogen. Senajan mengkono, fitoestrogen isa mudunake risiko kasebut kanti kapasitase berkompetisi karo estrogen ing pencerape, sahingga menstimulasi produksi [[globulin]] pengusung hormon seks lan ngalonake aktvitas enzim ing lintasa sintesis estrogen.
 
Nalika ngalami [[katabolisme]], estrogen bakal mbentuk pira-pira senyawa [[intermediat]] kang disebut estrogen-[[katekol]] lewati 2 [[lintasan metabolisme|lintasan]] ''2-hydroxylation'' karo enzim [[CYP1A1]] lan ''4-hydroxylation'' karo enzim [[CYP1B1]],<ref>{{en}}{{cite web